Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/19552093
其他信息:
PMID: 19552093
作者: Arif A Faruqui; Arif A Faruqui; Arif A Faruqui
摘要: The objective of this open, non-comparative, prospective postmarketing surveillance (PMS) study was to identify, validate and quantify the safety and efficacy associated with the use of fixed dose combination (FDC) of telmisartan 40 mg amlodipine 5 mg (T40 A5) in hypertensive patients with or without concomitant diabetes. The data was collected from 72 centres from all over India during the period of June 2007 to February 2008. A total of 251 patients of either sex and those who were newly dia...

